• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough.

作者信息

Nyenswah Tolbert G, Schue Jessica L

机构信息

Department of International Health, Johns Hopkins Bloomberg School of Public Health, MD, USA.

Department of International Health, Johns Hopkins Bloomberg School of Public Health, MD, USA.

出版信息

Lancet Glob Health. 2023 Jun;11(6):e811-e812. doi: 10.1016/S2214-109X(23)00161-4.

DOI:10.1016/S2214-109X(23)00161-4
PMID:37202011
Abstract
摘要

相似文献

1
Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough.阻止疫苗衍生脊髓灰质炎病毒的传播：新型2型口服疫苗可能还不够。
Lancet Glob Health. 2023 Jun;11(6):e811-e812. doi: 10.1016/S2214-109X(23)00161-4.
2
Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.口服脊髓灰质炎疫苗停用后接种灭活脊髓灰质炎疫苗
Wkly Epidemiol Rec. 2006 Apr 14;81(15):137-44.
3
Circulating vaccine derived poliovirus and the polio eradication endgame.循环疫苗衍生脊髓灰质炎病毒与脊髓灰质炎根除的最后阶段
Pan Afr Med J. 2012;12:109. Epub 2012 Aug 20.
4
Editorial from guest editors for Vaccine supplement: Vaccine-derived poliovirus type 2 outbreaks after the cessation of use of oral poliovirus vaccine type 2-2016-2021.
Vaccine. 2023 Apr 6;41 Suppl 1:A1. doi: 10.1016/j.vaccine.2023.02.082. Epub 2023 Mar 11.
5
The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting.在消灭脊灰病毒后环境中，使用灭活脊灰病毒疫苗进行常规免疫对野生型或疫苗衍生脊灰病毒暴发的潜在影响。
Am J Epidemiol. 2013 Nov 15;178(10):1579-87. doi: 10.1093/aje/kwt203. Epub 2013 Oct 7.
6
When can we stop using oral poliovirus vaccine?我们什么时候可以停止使用口服脊髓灰质炎疫苗？
J Infect Dis. 2005 Dec 15;192(12):2033-5. doi: 10.1086/498171. Epub 2005 Nov 8.
7
Current issues in evaluating the efficacy of oral poliovirus vaccine and inactivated poliovirus vaccine immunization.评估口服脊髓灰质炎疫苗和灭活脊髓灰质炎疫苗免疫效果的当前问题。
Pediatr Infect Dis J. 1991 Dec;10(12):979-81. doi: 10.1097/00006454-199112000-00032.
8
Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.在日本开发和引进源自 Sabin 株的脊髓灰质炎灭活疫苗。
Vaccine. 2016 Apr 7;34(16):1975-85. doi: 10.1016/j.vaccine.2014.11.015. Epub 2014 Nov 21.
9
On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.在全球从口服脊髓灰质炎病毒疫苗向灭活脊髓灰质炎病毒疫苗过渡过程中降低疫苗相关麻痹型脊髓灰质炎的风险
Lancet. 2018 Aug 18;392(10147):610-612. doi: 10.1016/S0140-6736(18)30483-5. Epub 2018 Apr 5.
10
Re: world wide experience with inactivated poliovirus vaccine.关于：全球使用灭活脊髓灰质炎病毒疫苗的经验。
Vaccine. 2009 Jan 1;27(1):1. doi: 10.1016/j.vaccine.2008.10.017. Epub 2008 Oct 24.

引用本文的文献

1
Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences.刚果民主共和国疫苗衍生脊髓灰质炎的再度出现：原因与后果
New Microbes New Infect. 2024 Sep 24;62:101489. doi: 10.1016/j.nmni.2024.101489. eCollection 2024 Dec.
2
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.新型口服脊髓灰质炎病毒疫苗 2 型（nOPV2）在 1 至<5 岁婴幼儿中的安全性和冈比亚婴幼儿对 nOPV2 免疫反应的批间一致性：一项 3 期、双盲、随机对照试验。
Lancet. 2024 Mar 23;403(10432):1164-1175. doi: 10.1016/S0140-6736(23)02844-1. Epub 2024 Feb 22.